These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 10755105

  • 1. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma.
    Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC.
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105
    [Abstract] [Full Text] [Related]

  • 2. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG, Maltezos A, Mantziris DA, Sine CS, Stewart WC.
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [Abstract] [Full Text] [Related]

  • 3. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C, Oksüz H.
    Ophthalmic Res; 2007 Jun; 39(1):24-31. PubMed ID: 17164574
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH, Gungel H, Altan C, Pasaoglu IB, Sabanci S.
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 12. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Jul; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 13. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 14. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 15. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M, Reis A, Sano ME, Susanna R.
    J Glaucoma; 2010 Dec; 19(5):331-5. PubMed ID: 19730119
    [Abstract] [Full Text] [Related]

  • 16. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ, Szaflik J, Czechowicz-Janicka K, Kałuzny J, Orzałkiewicz A, Zaleska-Zmijewska A, Krajewska M, Stewart JA, Leech JN, Stewart WC.
    Klin Oczna; 2004 Dec; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [Abstract] [Full Text] [Related]

  • 17. Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.
    Konstas AG, Kozobolis VP, Lallos N, Christodoulakis E, Stewart JA, Stewart WC.
    Eye (Lond); 2004 Dec; 18(12):1264-9. PubMed ID: 15218522
    [Abstract] [Full Text] [Related]

  • 18. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC.
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [Abstract] [Full Text] [Related]

  • 19. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.